Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model

Jun 16, 2017Neuroimmunomodulation

Removing the inflammation sensor Aim2 reduces amyloid buildup and immune cell activation but raises inflammatory signals in a mouse model of Alzheimer's disease

AI simplified

Abstract

Aim2 knockout mitigates Aβ deposition in the cerebral cortex and hippocampus of 5XFAD mice.

  • Deletion of Aim2 reduces the activation of microglial cells in the brains of 5XFAD mice.
  • Aim2 knockout does not improve spatial memory or anxiety-related behaviors in 5XFAD mice.
  • Il-1 expression levels remain unchanged in Aim2-/-;5XFAD mice compared to 5XFAD mice.
  • Aim2 deletion unexpectedly increases the expression levels of Il-6 and Il-18 in 5XFAD brains.
  • The findings suggest that Aβ aggregation and microglial activation may not correlate with inflammatory cytokine levels or cognitive function.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free